Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2016-03-16 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于下属公司药品注册的提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from the company's board about a subsidiary's drug registration status, referencing regulatory approval progress and promising further disclosure upon receipt of formal documents. It does not contain financial data, detailed reports, or voting results. It is a regulatory announcement related to compliance and disclosure requirements under stock exchange rules. The document length is only 472 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2016-03-16 Chinese
第一期员工持股计划管理办法（草案）
Capital/Financing Update Classification · 95% confidence The document is titled as the "First Employee Stock Ownership Plan Management Measures (Draft)" for Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It details the rules, management, rights, and obligations related to an employee stock ownership plan, including participation criteria, fund sources, management structure, meeting procedures, and share disposal methods. There is no indication that this is a financial report, earnings release, or regulatory filing about financial results. Instead, it is a detailed governance and procedural document about an employee stock ownership plan, which is a form of capital/financing update related to employee shareholding and fund management. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length (6814 characters) and content confirm it is a substantive plan document, not just an announcement or summary.
2016-03-15 Chinese
关于公司第一期员工持股计划的独立董事意见
Regulatory Filings Classification · 95% confidence The document is an independent directors' opinion on the company's first employee stock ownership plan, referencing relevant laws and regulations. It is a formal statement of approval and compliance rather than a financial report or announcement of voting results. It does not contain financial data, earnings, or management discussion. It is not a proxy solicitation or remuneration report. The document is a regulatory compliance opinion related to governance and employee stock plans, fitting best under Regulatory Filings (RNS) as it does not fit other specific categories.
2016-03-15 Chinese
天风证券天朦稳增1号集合资产管理计划集合资产管理合同
Regulatory Filings Classification · 95% confidence The document is a detailed contract titled "集合资产管理合同" (Collective Asset Management Contract) for a specific asset management plan named "天风证券天朦稳增中源协和1号集合资产管理计划". It includes comprehensive sections on definitions, parties involved, plan details, participation and exit procedures, fees, risk disclosures, and legal obligations. The content is consistent with a formal asset management contract outlining the terms and conditions of a collective investment scheme. It is not an announcement, summary, or presentation but the actual contract document governing the asset management plan. This fits the category of a regulatory or contractual filing related to asset management products. Given the filing categories, none exactly match a collective asset management contract, but the closest and most appropriate category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous filings that do not fit other specific categories. The document is lengthy (15,000 characters) and contains substantive contractual content, not a mere announcement or certification. Therefore, the classification is RNS with high confidence.
2016-03-15 Chinese
第八届监事会第十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a resolution passed by the supervisory board (监事会) of the company 中源协和细胞基因工程股份有限公司. It details the approval of an employee stock ownership plan draft and the voting results. The document is short (751 characters) and focuses on a board meeting decision rather than financial results or detailed reports. It does not contain financial statements or detailed financial data, nor is it a report or presentation. It is an official announcement of a board/management decision related to governance and employee stock plans. Therefore, it fits best under Board/Management Information (MANG).
2016-03-15 Chinese
职工代表大会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from the company's board regarding the resolution passed at the employee representative meeting about implementing an employee stock ownership plan. It includes statements about compliance, employee participation, and benefits of the plan. There is no financial data, no mention of annual or quarterly reports, no voting results from a general meeting, and no regulatory certifications. The document is an announcement of a board/management decision related to employee stock plans, which fits best under Board/Management Information (MANG). The document length is short and it is not a report or a notice of voting results, so it is not DVA or RPA. Therefore, the classification is MANG with high confidence.
2016-03-15 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.